DecisionMap Wealth Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$522K Sell
5,693
-907
-14% -$79.4K 0.29% 78
2026
Q1
$562K Buy
+6,600
New +$588K 0.36% 75
2025
Q4
Sell
-6,657
Closed -$532K 136
2025
Q3
$532K Buy
6,657
+330
+5% +$28.1K 0.34% 76
2025
Q2
$575K Buy
6,327
+86
+1% +$7.85K 0.39% 69
2025
Q1
$585K Buy
+6,241
New +$559K 0.44% 60

Other funds holding CL

DecisionMap Wealth Management's CL Position: Q2 2026 in Review

DecisionMap Wealth Management reduced its Colgate-Palmolive (CL) stake by 14% in Q2 2026, selling an estimated $79.4K and leaving 5,693 shares worth $522K. The position accounts for 0.29% of the portfolio, ranked #78.

DecisionMap Wealth Management first reported a position in CL in Q1 2025 and has held it in 5 quarters since. The position peaked at $585K in Q1 2025. 623 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • DecisionMap Wealth Management held 5,693 shares of Colgate-Palmolive worth $522K as of Q2 2026.
  • DecisionMap Wealth Management sold 907 Colgate-Palmolive shares in Q2 2026, an estimated $79.4K.
  • Colgate-Palmolive made up 0.29% of DecisionMap Wealth Management's portfolio in Q2 2026, its #78 holding.
  • DecisionMap Wealth Management first reported a position in Colgate-Palmolive in Q1 2025 and has held it in 5 quarters since.
  • DecisionMap Wealth Management's Colgate-Palmolive position peaked at $585K in Q1 2025.
  • 623 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on DecisionMap Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.